What Patients and Caregivers Need to Know
Senior Wellness
Cannabis and Neurodegenerative Disorders
What Patients and Caregivers Need to Know
THC by Sara Figueroa, contributing writer
As interest in medical cannabis continues to grow, many families affected by Alzheimer’ s disease, dementia, and Parkinson’ s disease are asking an important question: Can cannabis help?
Emerging research suggests that certain cannabinoids may help manage symptoms such as anxiety, agitation, sleep disturbances, pain, appetite loss, and quality-of-life challenges. Scientists are also investigating whether cannabinoids may provide neuroprotective effects by reducing inflammation and oxidative stress in the brain.
Understanding the Endocannabinoid System two primary receptors are CB1 receptors, which are abundant in the brain, and CB2 receptors, which are involved in immune and inflammatory processes.
Researchers have discovered that many neurodegenerative diseases involve chronic inflammation, oxidative stress, and deficiencies in the ECS. Cannabinoids from the cannabis plant may interact with these pathways and help restore balance.
Cannabis and Alzheimer’ s Disease
Alzheimer’ s disease is the most common cause of dementia. It involves the progressive loss of brain cells, leading to memory decline, confusion, behavioral changes, and eventually loss of independence.
Preclinical trials, meaning laboratory and animal studies, suggest that cannabinoids may reduce brain inflammation, decrease oxidative damage, and potentially influence the buildup of amyloid plaques associated with Alzheimer’ s disease. CBD has attracted particular interest because of its anti-inflammatory and antioxidant properties.
Clinical evidence in humans remains limited, however. Due to the highly varying nature of the way that cannabinoids affect individuals, there may never be a standardized clinical approach to treating neurodegenerative disorders with cannabis. The term clinicians use for this is“ magistral,” which means a physician assesses an individual dose for each patient and adjusts it according to the patient’ s response.
To understand how cannabis may help, it is important to understand how the body’ s endocannabinoid system( ECS) relates to neurodegenerative disorders.
A network of receptors found throughout the brain, nervous system, and immune system, the ECS helps regulate memory, mood, sleep, pain perception, appetite, inflammation, and movement. The
In recent years, the relationship between cannabinoids and neurodegenerative disease has become one of the fastest-growing bodies of research. One clinical study from 2024 showed exactly why— 94.9 % of the Alzheimer’ s patients in the study treated with full-spectrum CBD oil had more than a 30 % improvement in their neuropsychiatric symptoms, such as agitation and uncooperativeness. Alongside these improvements in patients’ quality of life, caregiver stress and burden were also significantly reduced.
26 August 2026